Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy

Background: Hepatitis B virus (HBV) reactivation may occur with chemotherapy and/or immunotherapy. Antiviral prophylaxis is recommended for all patients who are hepatitis B surface antigen (HBsAg)-positive during chemotherapy and/or immunosuppressive therapy. However, the optimal timing of antiviral...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cancer
Hoofdauteurs: Zou, Xiaofang, Guo, Longhua, Gu, Yinfang, Yang, Zhijun, Huang, Ping, Liu, Tianhuang, Zhao, Jingjing, Wu, Guowu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2020
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7150462/
https://ncbi.nlm.nih.gov/pubmed/32284752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.40154
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items